KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Precigen (PGEN) EBITDA (2016 - 2025)

Historic EBITDA for Precigen (PGEN) over the last 14 years, with Q3 2025 value amounting to -$34.5 million.

  • Precigen's EBITDA fell 6217.19% to -$34.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$117.4 million, marking a year-over-year increase of 1661.25%. This contributed to the annual value of -$135.0 million for FY2024, which is 3535.66% down from last year.
  • As of Q3 2025, Precigen's EBITDA stood at -$34.5 million, which was down 6217.19% from -$31.8 million recorded in Q2 2025.
  • Over the past 5 years, Precigen's EBITDA peaked at -$7.6 million during Q3 2022, and registered a low of -$60.8 million during Q2 2024.
  • Over the past 5 years, Precigen's median EBITDA value was -$22.6 million (recorded in 2025), while the average stood at -$25.6 million.
  • As far as peak fluctuations go, Precigen's EBITDA crashed by 19357.22% in 2021, and later surged by 6463.54% in 2022.
  • Precigen's EBITDA (Quarter) stood at -$21.9 million in 2021, then rose by 0.34% to -$21.8 million in 2022, then tumbled by 57.01% to -$34.2 million in 2023, then increased by 16.68% to -$28.5 million in 2024, then decreased by 20.92% to -$34.5 million in 2025.
  • Its EBITDA was -$34.5 million in Q3 2025, compared to -$31.8 million in Q2 2025 and -$22.6 million in Q1 2025.